Cite
HARVARD Citation
Lee, Y. et al. (2021). Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model. Journal for immunotherapy of cancer. 9 (3), p. . [Online].